RUBCN and diabetic kidney disease: Notably, upregulation of Rubicon was epidermal growth factor receptor (EGFR) signaling-dependent, and deletion of EGFR in glomerular podocytes ameliorated diabetic kidney disease via Rubicon suppression-dependent autophagic activation (Li et al., 2021).